Alignment Healthcare (ALHC) Reports Fiscal Q4 and Full Year 2025 Results

Alignment Healthcare, Inc. (NASDAQ:ALHC) is one of the best hot stocks under $20 to buy. Alignment Healthcare, Inc. (NASDAQ:ALHC) reported its fiscal Q4 and full year 2025 results on February 26, with full-year revenue of $3.95 billion, up 46.1% year-over-year. Adjusted gross profit for the full year was $494.8 million, while income from operations reached $14.8 million. The company exceeded the high-end of fiscal Q4 and full year guidance across all key metrics, including revenue, membership, adjusted gross profit, and adjusted EBITDA.

The company also raised its health plan membership guidance by 2,000 at the midpoint. In addition, it introduced 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30%-31% growth year-over-year, and adjusted EBITDA of $133 million to $163 million.

Alignment Healthcare, Inc. (NASDAQ:ALHC) further reported that total revenue for fiscal Q4 reached $1.012 billion, up 44.4% year-over-year. Health plan membership at the end of the quarter was around 236,300, reflecting a 25.0% year-over-year growth. The same day, William Blair reaffirmed a Buy rating on Alignment Healthcare, Inc. (NASDAQ:ALHC).

Alignment Healthcare, Inc. (NASDAQ:ALHC) offers a consumer-centric platform for delivering personalized healthcare solutions through its Medicare Advantage plans. The company also offers health options via its Alignment Health Plan.

While we acknowledge the potential of ALHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.